Find activities

101 results

  • Prescribed List - Clarifying definitions under the current Grouping Scheme

    We are clarifying and refining some definitions and descriptors for different categories of the Prescribed List (at the group, subgroup, and/or suffix level). This will be done under the current Grouping Scheme. We commenced this activity in response to enquiries received from stakeholders. We will continue this activity progressively over the coming months, with sets of definitions updated at a time. To ensure that the clarity objective is met, we will follow... More
    Closed 24 January 2025

  • Consultation: Draft National Allied Health Workforce Strategy

    The Department of Health and Aged Care, on behalf of the Australian Government, is working with state and territory governments to develop a National Allied Health Workforce Strategy, as recommended in the Independent review of Australia’s regulatory settings relating to overseas health practitioners Final Report . Development of the Draft Strategy has been led by a Strategy Steering Group. The group comprises Chief Allied Health Officers from each state and territory, as... More
    Opened 20 January 2025

  • National Lung Cancer Screening Program Guidelines Public Consultation

    The National Lung Cancer Screening Program (program) is an Australian Government initiative being implemented in partnership with the National Aboriginal Community Controlled Health Organisation (NACCHO). From July 2025, high-risk people aged between 50 and 70 years with a history of cigarette smoking of at least 30 pack-years will be able to get a free low-dose CT scan using fixed and mobile screening infrastructure every two years unless a screen detected abnormality is found... More
    Closed 5 January 2025

  • Medical Research Future Fund Australian Brain Cancer Mission - National Consultation on the refreshed Roadmap and Implementation Plan

    The Australian Brain Cancer Mission is investing $126.4 million over 10 years from 2017-18 to support research into brain cancer. This consists of $50 million from the Australian Government through the Medical Research Future Fund (MRFF) and $76.4 million to date in commitments from the Funding Partners. The Mission will make investments in research to achieve transformative improvement to the quality and length of life of people with brain cancer, with the longer term aim of... More
    Closed 20 December 2024

  • National Health and Medical Research Strategy - Webinar Survey

    The Minister for Health and Aged Care announced in May 2024 that the Australian Government would develop the National Health and Medical Research Strategy (National Strategy). The purpose of the National Strategy is to deliver: a plan to strengthen and leverage Australia’s world-leading research capability better health outcomes from a productive and efficient research ecosystem. At the conclusion of... More
    Opened 5 December 2024

  • Prescribed List Reforms - Billing code format (Part A, C and D)

    We reviewed stakeholder feedback from the billing code workshop on 18 October 2024. We considered the feedback in finalising the billing code format: AXNNN Where: X represents an alpha or a numeric character, and AX remains as sponsor-specific prefix (SupplierCode) We ask that you review the proposal and let us know of any technical contraints by Friday 8 November 2024. More
    Closed 8 November 2024

  • Public Health (Tobacco and Other Products) Amendment (On-Product Health Messages and Other Measures) Regulations 2024

    Public Consultation on the draft Public Health (Tobacco and Other Products) Amendment (On‑Product Health Messages and Other Measures) Regulations 2024 The Public Health (Tobacco and Other Products) Act 2023 (the Act) commenced on 1 April 2024. The objects of the Act are to: improve public health by discouraging smoking and the use of regulated tobacco items, and encouraging people to give up smoking and to stop using regulated tobacco items; give effect to... More
    Closed 8 November 2024

  • Proposed amendments to the Gene Technology Act 2000

    The Third Review (Review) of the National Gene Technology Scheme (Scheme) found that overall, the Scheme is working well and has operated successfully in assessing and managing the risks posed by genetically modified organisms (GMOs). The Review also identified opportunities to update and modernise the Scheme that would strengthen it and make sure it remains fit for purpose. The proposed amendments to Gene Technology Act 2000 (the GT Act) aim to ensure the Scheme... More
    Closed 8 November 2024

  • Medical Research Future Fund Genomics Health Futures Mission - National Consultation on the refreshed Roadmap and Implementation Plan

    The Genomics Health Futures Mission (GHFM) is investing $500.1 million over 10 years (2018-2028) in genomics research under the Medical Research Future Fund (MRFF). It will improve testing, diagnosis and treatment for genetic diseases, guide prevention and help personalise treatment options to better target and improve health outcomes and reduce unnecessary interventions and associated health costs for all Australians. A second Expert Advisory Panel was appointed in... More
    Closed 8 November 2024

  • Draft National Nursing Workforce Strategy

    The Department of Health and Aged Care, Victorian Department of Health and Safer Care Victoria, in collaboration with all jurisdictions, are developing Australia’s first National Nursing Workforce Strategy (the strategy). The strategy will establish priorities for enhancing the nursing workforce, aiming to bolster the delivery of health and aged care to all Australian communities. It offers a comprehensive framework to foster collaboration and drive action... More
    Closed 20 October 2024

  • Safe and Responsible Artificial Intelligence in Health Care – Legislation and Regulation Review

    Artificial Intelligence (AI) can help solve urgent and emerging challenges in our health care system and support the health care workforce dedicate more time to delivering care. However, along with the potential opportunities of AI in health care, there is community concern about the safety and risks of AI. There are concerns that current legislative and regulatory frameworks do not adequately mitigate potential for harm. There are high-risk use cases for AI in health care. ... More
    Closed 14 October 2024

  • 2024 Stoma Appliance Scheme Schedule Review

    The 2023-24 Budget included agreement to a comprehensive review of the Stoma Appliance Scheme (SAS) Schedule. The aim of the SAS Schedule Review (the Review) is to make sure all the products listed are clinically effective, correctly priced, and cost-effective. While there have been reviews of specific sub-groups or products on the SAS Schedule, there has been no comprehensive review of all products, pricing and groups since 2010. The Review is focusing on: the... More
    Closed 6 October 2024

  • Autism Health Roadmap Survey- short form

    Complete the survey You can provide your feedback by answering this survey, or you can email your comments to AutismRoadmapConsultation@health.gov.au Background The Australian Government Department of Health and Aged Care has listened to many Autistic people, their families and carers, and a range of experts to create a draft version of the National Roadmap to Improve the Health and Mental Health of Autistic People (the Autism Health Roadmap). ... More
    Closed 27 September 2024

  • Prescribed List Reforms - Consultation Paper 10 - General Use Items utilisation, expenditure and integrity

    On 1 May 2024, the Minister of Health and Aged Care announced that general use items (GUI) would be retained on Part D of the Prescribed List (PL). This decision follows consistent feedback from multiple stakeholders that removing the GUIs from the PL without an alternative funding arrangement would have negative clinical implications and potential adverse outcomes for patients. Some stakeholders raised concerns about the increasing growth in use per episode of care and... More
    Closed 20 September 2024

  • Prescribed List Reforms - Consultation Paper 9 - CIEDs and the cost of technical support services

    On 19 April 2024, stakeholders were provided with an update on the Technical support services component of the CIED PL benefit . This included the Medical Services Advisory Committee (MSAC) advice and associated public summary document. We are inviting stakeholders to provide views, suggestions, and ideas on how to implement the MSAC advice about the cost of technical support services (TSS) for cardiac implantable electronic devices (CIEDs). We ask that you raise any matters of... More
    Closed 6 September 2024

  • Prescribed List Reforms - Consultation Paper 8a - Gifts, benefits and discounts reporting requirements

    In July-August 2023, the department consulted on several proposed measures related to compliance, assurance, and information sharing as part of the reforms to the Prescribed List. Among the measures, was the requirement for hospitals to report any non-financial gifts or benefits received, such as a device or product listed on the Prescribed List (PL). Stakeholders raised concerns and questions around the proposed measure. As a result, we are undertaking additional consultation... More
    Closed 13 June 2024

  • Prescribed List Reforms - Consultation Paper 8b - Alignment of amount charged for supply of a device with corresponding PL benefit

    In July-August 2023, the department consulted on several proposed measures related to compliance, assurance, and information sharing as part of the reforms to the Prescribed List ( Consultation Paper 7 ). Among the measures, was the proposal to align the amount charged for the supply of a medical device or human tissue product with the corresponding PL benefit. Stakeholders raised concerns and questions around the proposed measure. As a result, we are undertaking additional consultation... More
    Closed 13 June 2024

  • Quality Use of Diagnostics, Therapeutics and Pathology (QUDTP) Program - Stakeholder Forum

    The Department of Health and Aged Care is seeking to engage stakeholders regarding the Quality Use of Diagnostics, Therapeutics and Pathology (QUDTP) Program . The QUDTP provides funding to improve the way medicines and medical tests are prescribed and used. As part of the QUDTP Program, two grant opportunities are delivered: Health Professional Education Grant Program – focusing on educational (academic) activities for... More
    Closed 16 April 2024

  • Consultation on the Condition for surgical guides and biomodels on the Prescribed List

    On 13 November 2023, a con dition for reimbursement was placed on 37 billing codes for surgical guides and biomodels listed in Part A of Schedule 1 to the Private Health Insurance (Medical Devices and Human Tissue Products) Rules (No. 2) 2023 (the condition). The condition is as follows: Prescribed List reimbursement is restricted to the use of the device in craniomaxillofacial surgery procedures involving insertion of an implantable medical... More
    Closed 25 March 2024

  • Consultation on a draft National Gene Drive Policy Guide

    In order to give proponents of gene drive technology greater regulatory certainty and understanding of the risk considerations, a new National Gene Drive Policy Guide (the Guide) has been developed. A copy of the Guide is attached below at the bottom of the screen and can also be found on the National Gene Technology Scheme website. Read the Guide. Consultation on the guide has now closed. More
    Closed 3 March 2024

  • Southcentral Foundation - Nuka System of Care

    South Central Foundation Webinar – Nuka System of Care Date/Time Thursday 30 November 2023, 9:00am-10:30 a.m. (Australian Eastern Standard Time Intended audience Organisations and policymakers interested in First Nations health policies. Background South Central Foundation’s (SCF) Nuka System of Care provides medical, dental, behavioural, and traditional health care support services... More
    Closed 15 January 2024

  • Public Health (Tobacco and Other Products) Regulations 2023

    Supplementary Public Consultation on the Public Health (Tobacco and Other Products) Regulations The Australian Government is undertaking a supplementary public consultation regarding graphic health warnings and health promotion inserts. Updates to these Regulations have been informed from public consultation on the exposure draft released on 31 May 2023 and also includes images of proposed health warnings and health promotion inserts. These Regulations will support the... More
    Closed 8 January 2024

  • Medicare Benefits Schedule Review Advisory Committee Draft Report: Post Implementation Review of Telehealth MBS items

    The Medicare Benefits Schedule (MBS) is a list of health professional services (items) that the Australian Government subsidises. MBS items provide patient benefits for a wide range of health services including consultations, diagnostic tests, therapy, and operations. When changes are made to MBS items, a review is undertaken approximately 24 months after to analyse and examine the performance of the changes. This is called a post implementation review. Post... More
    Closed 6 November 2023

  • Modernising My Health Record – Sharing pathology and diagnostic imaging reports by default and removing consumer access delays

    In February 2023 the Minister for Health and Aged Care released the Strengthening Medicare Taskforce Report . The report recommended that the government: Modernise My Health Record to significantly increase health information available to consumers and their health care professionals, including by requiring sharing by default for private and public practitioners and services, and make it easier for people and their health care teams to use at the point of care. ... More
    Closed 31 October 2023

  • Unleashing the potential of our workforce - Scope of Practice Review

    In February 2023, the Strengthening Medicare Taskforce Report outlined priority recommendations to improve primary care. One of these was that the Australian Government work together with states and territories to explore the barriers and incentives for all health practitioners to work to their full scope of practice. In April 2023, National Cabinet supported this recommendation. As part of the 2023-24 Budget, the Government provided funding for a review of the scope of... More
    Closed 16 October 2023

  • Prostheses List Reforms – PwC Report on Reforms to the Prostheses List Part B – May 2023

    We are seeking feedback from stakeholders on the PricewaterhouseCoopers' (PwC) report and recommendations on the proposed reforms to Part B of the Prescribed List of Benefits for Medical Devices and Human Tissue Products* (the PL), and the proposed restructure of Part B. The report outlines a way forward agreed between the department and key stakeholders in terms of the new structure of Part B, and the listing process to be used for new products, and also includes amendments to... More
    Closed 6 October 2023

  • Draft National Consumer Engagement Strategy for Health and Wellbeing

    A NATIONAL CONSUMER ENGAGEMENT STRATEGY FOR HEALTH AND WELLBEING: This Strategy is designed to strengthen partnerships between health policy makers and the community, as set out in one of the immediate priorities for action under the National Preventive Health Strategy 2021-2030. The purpose of this Strategy is to mobilise a person-centred prevention system by involving communities and consumers in preventive health policy design and implementation in order to enable and support a more... More
    Closed 4 September 2023

  • Consultation on the Private Health Insurance (PHI) Incentives and Hospital Default Benefits Studies

    Independent studies were announced in the 2020-21 and 2021-22 Budgets and covered the following: The effectiveness of the regulatory settings for the Medicare Levy Surcharge (MLS), Rebate, and Lifetime Health Cover (LHC) (collectively referred to as the PHI Incentives); and Hospital Default Benefits. The aim of these studies is to identify opportunities to improve the affordability and quality of PHI cover for consumers to access private... More
    Closed 15 August 2023

  • Prostheses List Reforms Consultation Paper 7 - Proposed measures for compliance, assurance and information sharing

    The purpose of this paper is to provide stakeholders information about: proposed compliance and assurance measures; and proposed measures to promote information sharing among government agencies about medical devices and human tissue products included in the Prescribed List . As part of this consultation, we invited stakeholders to attend an information webinar on Tuesday 1 August 2023, where we discussed the proposed measures, answered... More
    Closed 10 August 2023

  • Improving alignment and coordination between the Medical Research Future Fund and Medical Research Endowment Account

    This consultation closed on 14 July 2023. The Australian Government is committed to ensuring health and medical research investment delivers the greatest benefit to the community while driving long-term economic sustainability. To optimise the government’s investment in health and medical research, the Department of Health and Aged Care and National Health and Medical Research Council (NHMRC) are undertaking national consultation to improve alignment and coordination... More
    Closed 14 July 2023
101 results. Page 1 of 4